Metabolomics in Bone Research
Open Access
- 1 July 2021
- journal article
- review article
- Published by MDPI AG in Metabolites
- Vol. 11 (7) , 434
Abstract
Identifying the changes in endogenous metabolites in response to intrinsic and extrinsic factors has excellent potential to obtain an understanding of cells, biofluids, tissues, or organisms’ functions and interactions with the environment. The advantages provided by the metabolomics strategy have promoted studies in bone research fields, including an understanding of bone cell behaviors, diagnosis and prognosis of diseases, and the development of treatment methods such as implanted biomaterials. This review article summarizes the metabolism changes during osteogenesis, osteoclastogenesis, and immunoregulation in hard tissue. The second section of this review is dedicated to describing and discussing metabolite changes in the most relevant bone diseases: osteoporosis, bone injuries, rheumatoid arthritis, and osteosarcoma. We consolidated the most recent finding of the metabolites and metabolite pathways affected by various bone disorders. This collection can serve as a basis for future metabolomics-driven bone research studies to select the most relevant metabolites and metabolic pathways. Additionally, we summarize recent metabolic studies on metabolomics for the development of bone disease treatment including biomaterials for bone engineering. With this article, we aim to provide a comprehensive summary of metabolomics in bone research, which can be helpful for interdisciplinary researchers, including material engineers, biologists, and clinicians.Keywords
Funding Information
- Horizon 2020 (857287, 898858)
This publication has 144 references indexed in Scilit:
- Aminoacyl‐tRNA synthetases in medicine and diseaseEMBO Molecular Medicine, 2013
- Metabolomic Profiles Delineate Signature Metabolic Shifts during Estrogen Deficiency-Induced Bone Loss in Rat by GC-TOF/MSPLOS ONE, 2013
- Analysis of colorectal cancers in British Bangladeshi identifies early onset, frequent mucinous histotype and a high prevalence of RBFOX1 deletionMolecular Cancer, 2013
- Tumor glycolysis as a target for cancer therapy: progress and prospectsMolecular Cancer, 2013
- Effect of Antiresorptive Therapy on Urinary Hydroxyproline in Postmenopausal OsteoporosisIndian Journal of Clinical Biochemistry, 2011
- The role of tumour necrosis factor- and tumour necrosis factor receptor signalling in inflammation-associated systemic genotoxicityMutagenesis, 2011
- PPARγ: a circadian transcription factor in adipogenesis and osteogenesisNature Reviews Endocrinology, 2010
- Increased Lipid Oxidation Causes Oxidative Stress, Increased Peroxisome Proliferator-activated Receptor-γ Expression, and Diminished Pro-osteogenic Wnt Signaling in the SkeletonJournal of Biological Chemistry, 2009
- Indoleamine 2,3-dioxygenase is a critical regulator of acute graft-versus-host disease lethalityBlood, 2008
- Regulation of immune responses by L-arginine metabolismNature Reviews Immunology, 2005